| Period Ending | Mar 31, 2012 | Mar 31, 2011 | Mar 31, 2010 | Mar 31, 2009 |
|---|
|
Total Revenue
|
14,858,000
|
14,525,000
|
12,707,000
|
15,996,000
| | Cost of Revenue | 11,837,000 | 10,425,000 | 9,779,000 | 12,219,000 | | |
Gross Profit
|
3,021,000
|
4,100,000
|
2,928,000
|
3,777,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 14,610,000 | 13,246,000 | 12,624,000 | 14,982,000 | | | |
Operating Income or Loss
|
248,000
|
1,279,000
|
83,000
|
1,014,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 248,000 | 1,279,000 | 83,000 | 1,014,000 |
|
Interest Expense | (72,000) | (68,000) | (67,000) | (84,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 51,000 | 270,000 | 6,000 | 52,000 |
|
Minority Interest | (61,000) | (57,000) | (64,000) | (85,000) |
|
|
|
Net Income From Continuing Ops | 397,000 | 1,149,000 | 280,000 | 1,147,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
336,000
|
1,092,000
|
216,000
|
1,062,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
1.77%